Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

General Information

Genetic Technologies Limited
Life Sciences Tools & Services

Current Price Data+

Current Price Open High Low Last Close Volume Price Movement
$0.03 $0.03 $0.03 $0.03 $0.03 464093 - ( No change )
  • +Security prices are delayed by least 20 minutes and are indicative only.

Company Overview

Business Description
Genetic Technologies Limited (GTG) is a biotechnology company engaged in genetic testing service business, licensing its intellectual property relating to non-coding DNA and conducting research activities on the impact of DNA on health. GTG has operations in Australia, China, Canada, Switzerland and USA. Its primary focus is diagnostic products for cancer management. GTG provides genetic tests products & services in three areas: Medical, Paternity and Animal.
Strategy Analysis

Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2014 A -10.1 -1.8 0.0% 0.0 0.0 0.0% 0.0%
2013 A -9.3 -2.0 0.0% 0.0 0.0 0.0% 0.0%
2012 A -10.4 -2.3 0.0% 0.0 0.0 0.0% 0.0%

Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2012 A 2013 F 2014 F 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F
Genetic Technologies (GTG) $50M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

Financial Summary

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 10.74 0.00
Market 0.97 13.50 1.05 0.47
Sector 0.81 13.20 3.15 1.03


Name Position Start Date
Mr Eutillio Buccilli Chief Financial Officer, Chief Operating Officer, Chief Executive Officer, Executive Director 12/06/2015
Professor Ian McKenzie Non-Executive Director 29/11/2013
Mr Grahame Leonard Non-Executive Director 29/11/2013
Dr Paul Kasian Non-Executive Director 12/12/2013
Dr Lindsay Peter Wakefield Non-Executive Director 24/09/2014
Dr Malcolm Roy Brandon Non-Executive Director, Non-Executive Chairman 05/10/2009


Name Position
Eutillio Buccilli Chief Financial Officer
Brian Manuel Chief Financial Officer,Joint Company Secretary
Bronwyn Chrisite Company Secretary
M. Luisa Ashdown Director of Global Licensing and Intellectual Property
Diana Newport Quality and Business Operations Director
Dr Richard Allman Scientific Director
Mark J Ostrowski Sr. VP Sales and Marketing - Phenogen Sciences Inc.

Calendar of Events

Date Event
26 February 2016 Report (Interim)
29 October 2015 Report (Annual)
27 October 2015 Report (Quarterly)
26 October 2015 Report (Annual)
28 August 2015 Report (Prelim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.